Developer docs
API playgroundTry for free, no card

Search company profiles

LymphaTech

Full company profile

uuid000bfjw

Namestring
LymphaTech
Legal namestring
LymphaTech Inc.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

LymphaTech is a privately held medical technology company founded in 2014 and headquartered in Atlanta, Georgia. The company developed a digital 3D full-body measurement and monitoring platform for the assessment, monitoring, and management of lymphedema, a chronic swelling condition estimated to affect approximately 20 million symptomatic patients in the United States. The platform combines proprietary 3D scanning technology with a Bluetooth-enabled tape measure and a companion mobile application, addressing physical therapy, oncology, and compression garment professionals as primary customers, with a secondary self-measurement use case for patients at home.

The core LymphaTech 3D Measuring System uses iPad-based scanning hardware with software algorithms to capture limb geometry, claiming 99% accuracy versus water displacement for volume and tape measure for circumference, validated through external clinical research. Measurements are completed in under one minute, and the mobile app automatically calculates volumes and longitudinal differences from synced data. The Bluetooth Tape Measure forms an automated loop around the limb and transfers measurements directly to the app, eliminating transcription errors and enabling home monitoring. A separate Compression Garments module integrates scan data with ecommerce ordering platforms, reducing garment remake errors by 33%. The company holds 9 issued US patents covering swelling evaluation methods and therapeutic compression garment fitting systems, and claims more than 300,000 measurements performed and 1,000+ users globally.

LymphaTech sold primarily through direct website sales and outbound sales to healthcare professionals, with quote-based subscription pricing for the clinical 3D system, hardware sales for the consumer Bluetooth Tape Measure, and a transaction fee component tied to garment ordering integrations. Revenue is not publicly disclosed. In Q4 2025, LymphaTech was acquired by Tactile Systems Technology (NASDAQ: TCMD, "Tactile Medical") for $6.8 million in upfront cash plus potential milestone-based additional payments, becoming part of Tactile Medical's integrated lymphedema solutions portfolio and shifting Tactile Medical's positioning from a product-based company to a disease identification and progression tracking provider.

Short descriptiontext

LymphaTech is a healthcare technology company that developed a 3D scanning and Bluetooth measurement platform for assessing, monitoring, and fitting compression garments for lymphedema patients. It served physical therapy, oncology, and compression garment professionals before being acquired by Tactile Medical in Q4 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAtlanta, United States
HQ citystring
Atlanta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
3D body scanning, lymphedema measurement, compression garment fitting, digital health monitoring, medical measurement devices
Industry3 codes
1High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening)
CodeHLAAAIAAPrimaryYes
2Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
CodeHLAAALAHPrimaryNo
3Microscopy, Imaging & Flow Cytometry Instruments
CodeHLAGAIAEPrimaryNo
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Medical Measurement Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
13D Measuring System
TypeSubscription Recurring
Description

LymphaTech provides measurement solutions to healthcare professionals. The system includes hardware (iPad-based 3D scanning) and software for clinical assessment and monitoring of lymphedema patients.

lymphatech.com
2Bluetooth Tape Measure
TypeHardware Sales
Description

Consumer/self-measurement device sold for home use that syncs with the LymphaTech app, enabling patients to take measurements independently.

lymphatech.com
3Compression Garment Integration Services
TypeTransaction Fee
Description

Software facilitates garment ordering based on measurements with direct connection to ecommerce platforms for compression garment fitting.

lymphatech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Pricing details1 tier
1Quote-based pricing for healthcare professionals
ModelSubscriptionBilling cadenceMonthly
Notes

Healthcare professionals (Physical Therapy, Oncology, Compression Garment professionals) must request pricing through contact forms. No public pricing listed.

lymphatech.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1LymphaTech Platform
Description

Digital 3D full-body measurement and monitoring platform for lymphedema assessment

lymphatech.com
+1 more record
Core offering1 text field

LymphaTech develops and sells a 3D full-body measurement and monitoring platform for lymphedema assessment. The offering combines iPad-based 3D scanning hardware, a Bluetooth-enabled tape measure, and mobile app software that automatically calculates volume and circumference measurements with claimed 99% accuracy compared to gold-standard methods. It is sold to healthcare professionals (physical therapy, oncology, compression garment) for clinical use and to patients for at-home self-measurement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 99% accuracy compared to water displacement for volume measurement and tape measure for circumference, validated through external clinical research
+2 more records
Product overview1 text field

LymphaTech offers a unified 3D measuring platform for lymphedema assessment and monitoring. The portfolio consists of a core 3D Measuring System complemented by three integrated solutions: the Clinical Practice module for healthcare providers, the Compression Garments module for garment fitting and ordering, and the Bluetooth Tape Measure for home self-measurement. The system connects these modules through its app, where measurements automatically sync and algorithms calculate volumes. The platform is used by over 1,000 users across physical therapy, oncology, and compression garment professionals. LymphaTech was acquired by Tactile Medical in Q4 2025 for $6.8 million upfront cash plus potential milestone payments.

Product and service4 records
1LymphaTech 3D Measuring System
Category3D Medical Measurement Platform
Description

An automated 3D scanning solution that captures full-body measurements for lymphedema assessment. The iPad-based system measures volume and circumference with 99% accuracy compared to water displacement and tape measure respectively, validated through external clinical research. Sold to healthcare professionals and integrated with the LymphaTech mobile app for longitudinal tracking.

2Clinical Practice Solution
CategoryClinical Measurement Solution
Description

Measurement solution sold to physical therapy, oncology, and other healthcare professionals for lymphedema assessment. Enables clinicians to capture exact geometry, detect subtle changes in volume and circumference, and track disease progression over time through longitudinal monitoring.

3Compression Garments Solution
CategoryGarment Fitting Solution
Description

3D scanning and measurement system for compression garment fitting professionals. Acquires 3D scans and standardized measurements in under 1 minute, optimized for compression garment sizing, and includes software that facilitates garment ordering through direct integration with ecommerce platforms. The company claims a 33% reduction in garment remake errors.

4Bluetooth Tape Measure
CategoryConsumer Measurement Device
Description

A Bluetooth-enabled measuring device sold for home use that forms a loop and automatically tightens around the limb, transferring measurements directly to the LymphaTech mobile app. Enables patients to perform self-measurements at home with automated volume calculation, removing transcription errors and supporting remote patient monitoring, particularly for rural users.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LymphaTech was acquired by Tactile Systems Technology in Q4 2025 for $6.8 million upfront cash plus potential milestone-based additional payments. The acquisition adds LymphaTech's digital 3D full-body measurement and monitoring platform to Tactile Medical's lymphedema portfolio, advancing the company's evolution from a product-based company to an integrated lymphedema solutions leader. LymphaTech strengthens Tactile Medical's capabilities in disease identification and progression tracking.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Provider of high-precision 3D body scanning systems used in healthcare, research, and plastic surgery. Comparable technology category (3D surface imaging) with overlap in clinical measurement applications adjacent to lymphedema assessment.

TypeOthers
Description

Global compression garment manufacturer featured as a customer/partner on LymphaTech's website. Sits in the lymphedema care value chain alongside LymphaTech as a downstream garment supplier that benefits from standardized measurement inputs.

TypeOthers
Description

Major compression therapy and lymphedema garment manufacturer. Sits in the same clinical workflow as LymphaTech and is a potential integration partner for LymphaTech's garment-ordering software.

TypeOthers
Description

Established compression therapy brand (part of Essity) serving the lymphedema and venous disease markets. Operates in the same downstream garment fitting workflow where LymphaTech's measurement-driven ordering integration is targeted.

5Pero-System (Perometer)
TypeDirect peer
Description

German manufacturer of the Perometer, an optoelectronic limb volume measurement device widely used in lymphedema research and clinical assessment. Direct competitor in automated limb volume measurement for lymphedema.

TypeEmerging player
Description

Innovator of wearable, mobile compression therapy for lymphedema and chronic venous disease. Targets the same lymphedema patient population with an active treatment product and is increasingly integrating connected, patient-facing measurement and monitoring.

TypeEmerging player
Description

Provider of 3D body scanning solutions for apparel, healthcare, and fitness. Comparable 3D scanning technology stack and mobile app integration, with overlapping applications in body measurement and remote sizing.

TypeDirect peer
Description

ASX-listed medical device company whose L-Dex bioimpedance spectroscopy device is used for lymphedema assessment in breast cancer survivorship. Direct competitor in the clinical lymphedema measurement category, addressing the same oncology and PT clinicians.

TypeDirect peer
Description

Public NASDAQ-listed parent company of LymphaTech and a leading provider of lymphedema compression therapy products. Directly comparable as it serves the same clinical customers (PT, oncology, vascular) and now bundles LymphaTech's measurement platform with its therapeutic products.

TypeDirect peer
Description

Manufacturer of pneumatic compression pumps and garment systems for lymphedema and venous disease. Competes in the same lymphedema treatment workflow where LymphaTech's measurement technology is deployed.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LymphaTech

Medical Measurement Deviceslymphatechnology.com

LymphaTech is a healthcare technology company that developed a 3D scanning and Bluetooth measurement platform for assessing, monitoring, and fitting compression garments for lymphedema patients. It served physical therapy, oncology, and compression garment professionals before being acquired by Tactile Medical in Q4 2025.

What LymphaTech does

LymphaTech is a privately held medical technology company founded in 2014 and headquartered in Atlanta, Georgia. The company developed a digital 3D full-body measurement and monitoring platform for the assessment, monitoring, and management of lymphedema, a chronic swelling condition estimated to affect approximately 20 million symptomatic patients in the United States. The platform combines proprietary 3D scanning technology with a Bluetooth-enabled tape measure and a companion mobile application, addressing physical therapy, oncology, and compression garment professionals as primary customers, with a secondary self-measurement use case for patients at home.

The core LymphaTech 3D Measuring System uses iPad-based scanning hardware with software algorithms to capture limb geometry, claiming 99% accuracy versus water displacement for volume and tape measure for circumference, validated through external clinical research. Measurements are completed in under one minute, and the mobile app automatically calculates volumes and longitudinal differences from synced data. The Bluetooth Tape Measure forms an automated loop around the limb and transfers measurements directly to the app, eliminating transcription errors and enabling home monitoring. A separate Compression Garments module integrates scan data with ecommerce ordering platforms, reducing garment remake errors by 33%. The company holds 9 issued US patents covering swelling evaluation methods and therapeutic compression garment fitting systems, and claims more than 300,000 measurements performed and 1,000+ users globally.

LymphaTech sold primarily through direct website sales and outbound sales to healthcare professionals, with quote-based subscription pricing for the clinical 3D system, hardware sales for the consumer Bluetooth Tape Measure, and a transaction fee component tied to garment ordering integrations. Revenue is not publicly disclosed. In Q4 2025, LymphaTech was acquired by Tactile Systems Technology (NASDAQ: TCMD, "Tactile Medical") for $6.8 million in upfront cash plus potential milestone-based additional payments, becoming part of Tactile Medical's integrated lymphedema solutions portfolio and shifting Tactile Medical's positioning from a product-based company to a disease identification and progression tracking provider.

LymphaTech firmographics

Firmographics
Name
LymphaTech
Legal name
LymphaTech Inc.
Website
https://lymphatechnology.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
1–10 employees
Short description
LymphaTech is a healthcare technology company that developed a 3D scanning and Bluetooth measurement platform for assessing, monitoring, and fitting compression garments for lymphedema patients. It served physical therapy, oncology, and compression garment professionals before being acquired by Tactile Medical in Q4 2025.
Ownership category
akta.pro rank

LymphaTech industry classification

Industry
Product category
Medical Measurement Devices
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Medical and Diagnostic Laboratories (62151)
SIC
Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)
akta.pro secondary industries
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

Keywords

  • 3D body scanning
  • Lymphedema measurement
  • Compression garment fitting
  • Digital health monitoring
  • Medical measurement devices

Where LymphaTech is headquartered

Location

Headquarters

HQ city
Atlanta
HQ country
United States
HQ region
North America

Markets served

LymphaTech business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. 3D Measuring System: LymphaTech provides measurement solutions to healthcare professionals. The system includes hardware (iPad-based 3D scanning) and software for clinical assessment and monitoring of lymphedema patients.
  2. Bluetooth Tape Measure: Consumer/self-measurement device sold for home use that syncs with the LymphaTech app, enabling patients to take measurements independently.
  3. Compression Garment Integration Services: Software facilitates garment ordering based on measurements with direct connection to ecommerce platforms for compression garment fitting.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyQuote-based pricing for healthcare professionals

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

LymphaTech product offering

Product offering

Core offering

LymphaTech develops and sells a 3D full-body measurement and monitoring platform for lymphedema assessment. The offering combines iPad-based 3D scanning hardware, a Bluetooth-enabled tape measure, and mobile app software that automatically calculates volume and circumference measurements with claimed 99% accuracy compared to gold-standard methods. It is sold to healthcare professionals (physical therapy, oncology, compression garment) for clinical use and to patients for at-home self-measurement.

Product overview

LymphaTech offers a unified 3D measuring platform for lymphedema assessment and monitoring. The portfolio consists of a core 3D Measuring System complemented by three integrated solutions: the Clinical Practice module for healthcare providers, the Compression Garments module for garment fitting and ordering, and the Bluetooth Tape Measure for home self-measurement. The system connects these modules through its app, where measurements automatically sync and algorithms calculate volumes. The platform is used by over 1,000 users across physical therapy, oncology, and compression garment professionals. LymphaTech was acquired by Tactile Medical in Q4 2025 for $6.8 million upfront cash plus potential milestone payments.

Differentiator

Problem solved

Functional benefit

Brands

  • LymphaTech Platform: Digital 3D full-body measurement and monitoring platform for lymphedema assessment
  • Bluetooth Tape Measure

Products and services

  • LymphaTech 3D Measuring System An automated 3D scanning solution that captures full-body measurements for lymphedema assessment. The iPad-based system measures volume and circumference with 99% accuracy compared to water displacement and tape measure respectively, validated through external clinical research. Sold to healthcare professionals and integrated with the LymphaTech mobile app for longitudinal tracking.
  • Clinical Practice Solution Measurement solution sold to physical therapy, oncology, and other healthcare professionals for lymphedema assessment. Enables clinicians to capture exact geometry, detect subtle changes in volume and circumference, and track disease progression over time through longitudinal monitoring.
  • Compression Garments Solution 3D scanning and measurement system for compression garment fitting professionals. Acquires 3D scans and standardized measurements in under 1 minute, optimized for compression garment sizing, and includes software that facilitates garment ordering through direct integration with ecommerce platforms. The company claims a 33% reduction in garment remake errors.
  • Bluetooth Tape Measure A Bluetooth-enabled measuring device sold for home use that forms a loop and automatically tightens around the limb, transferring measurements directly to the LymphaTech mobile app. Enables patients to perform self-measurements at home with automated volume calculation, removing transcription errors and supporting remote patient monitoring, particularly for rural users.

Quantifiable outcome

  • 99% accuracy compared to water displacement for volume measurement and tape measure for circumference, validated through external clinical research
  • +2 more outcomes

Companies that use LymphaTech

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

LymphaTech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

LymphaTech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Tactile Systems Technology (Tactile Medical)coreStrategic or Co-development PartnerLymphaTech was acquired by Tactile Systems Technology in Q4 2025 for $6.8 million upfront cash plus potential milestone-based additional payments. The acquisition adds LymphaTech's digital 3D full-body measurement and monitoring platform to Tactile Medical's lymphedema portfolio, advancing the company's evolution from a product-based company to an integrated lymphedema solutions leader. LymphaTech strengthens Tactile Medical's capabilities in disease identification and progression tracking.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

LymphaTech competitors and assessment

Company assessment

Emerging players

  • 3dMD: Provider of high-precision 3D body scanning systems used in healthcare, research, and plastic surgery. Comparable technology category (3D surface imaging) with overlap in clinical measurement applications adjacent to lymphedema assessment.
  • Koya Medical: Innovator of wearable, mobile compression therapy for lymphedema and chronic venous disease. Targets the same lymphedema patient population with an active treatment product and is increasingly integrating connected, patient-facing measurement and monitoring.
  • Size Stream: Provider of 3D body scanning solutions for apparel, healthcare, and fitness. Comparable 3D scanning technology stack and mobile app integration, with overlapping applications in body measurement and remote sizing.

Others

  • medi (medi USA): Global compression garment manufacturer featured as a customer/partner on LymphaTech's website. Sits in the lymphedema care value chain alongside LymphaTech as a downstream garment supplier that benefits from standardized measurement inputs.
  • Sigvaris Group: Major compression therapy and lymphedema garment manufacturer. Sits in the same clinical workflow as LymphaTech and is a potential integration partner for LymphaTech's garment-ordering software.
  • BSN Medical (Jobst): Established compression therapy brand (part of Essity) serving the lymphedema and venous disease markets. Operates in the same downstream garment fitting workflow where LymphaTech's measurement-driven ordering integration is targeted.

Direct peers

  • Pero-System (Perometer): German manufacturer of the Perometer, an optoelectronic limb volume measurement device widely used in lymphedema research and clinical assessment. Direct competitor in automated limb volume measurement for lymphedema.
  • ImpediMed: ASX-listed medical device company whose L-Dex bioimpedance spectroscopy device is used for lymphedema assessment in breast cancer survivorship. Direct competitor in the clinical lymphedema measurement category, addressing the same oncology and PT clinicians.
  • Tactile Systems Technology (Tactile Medical): Public NASDAQ-listed parent company of LymphaTech and a leading provider of lymphedema compression therapy products. Directly comparable as it serves the same clinical customers (PT, oncology, vascular) and now bundles LymphaTech's measurement platform with its therapeutic products.
  • BioCompression Systems: Manufacturer of pneumatic compression pumps and garment systems for lymphedema and venous disease. Competes in the same lymphedema treatment workflow where LymphaTech's measurement technology is deployed.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

LymphaTech social profiles

Digital presence

LymphaTech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LymphaTech leadership team

Management profile

Number of profiles

LymphaTech funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LymphaTech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LymphaTech

What does LymphaTech do?

LymphaTech develops and sells a 3D full-body measurement and monitoring platform for lymphedema assessment. The offering combines iPad-based 3D scanning hardware, a Bluetooth-enabled tape measure, and mobile app software that automatically calculates volume and circumference measurements with claimed 99% accuracy compared to gold-standard methods. It is sold to healthcare professionals (physical therapy, oncology, compression garment) for clinical use and to patients for at-home self-measurement.

Is LymphaTech a public or private company?

LymphaTech is a private company. It is classified as corporate owned and is currently acquired.

When was LymphaTech founded?

LymphaTech was founded in 2014. It employs 1 to 10 people.

Where is LymphaTech based?

LymphaTech is headquartered in Atlanta, United States, in the North America region.

How does LymphaTech make money?

Three revenue lines are on record. 3D Measuring System is the primary driver. The others are bluetooth Tape Measure and compression Garment Integration Services.

Who are LymphaTech's main competitors?

Emerging players on record are 3dMD, Koya Medical and Size Stream. Others are medi (medi USA), Sigvaris Group and BSN Medical (Jobst). Direct peers are Pero-System (Perometer), ImpediMed, Tactile Systems Technology (Tactile Medical) and BioCompression Systems.

Does LymphaTech have an API?

No public API is recorded for LymphaTech.

What industry is LymphaTech in?

LymphaTech's product category is Medical Measurement Devices. Its primary akta.pro industry code is HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening), with a secondary code of HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing). Its NAICS code is 334516 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePhysiotherapy Equipment Market worth $8.37 billion by 2031 - Exclusive Report by MarketsandMarkets™MarketsandMarkets projects the physiotherapy equipment market to grow from $6.11 billion in 2026 to $8.37 billion by 2031, a 6.5% CAGR. North America holds the largest share at 30-35% in 2025, and the musculoskeletal & orthopedic segment dominates by application.BenzingaFull Transcript: Tactile Systems Tech Q1 2026 Earnings Call - Tactile Systems Tech (NASDAQ:TCMD)Tactile Systems Technology reported Q1 2026 revenue of $75.3 million, a 23% year-over-year increase, with lymphedema products generating $62.2 million and airway clearance products contributing $13 million. The company improved gross margins by 250 basis points to 76.5% and achieved positive adjusted EBITDA of $3.7 million compared to an adjusted EBITDA loss in the prior year period. Tactile Systems raised its full-year 2026 revenue guidance to $360-$368 million, reflecting confidence in commercial execution and the inclusion of revenue from the recently acquired LymphaTech, while also receiving FDA clearance for its next-generation AfloVest device.GlobeNewswireTactile Systems Technology, Inc. Reports First Quarter 2026 Financial ResultsTactile Medical reported Q1 2026 revenue of $75.3 million, up 23% year-over-year, with gross margin of 76.5% and adjusted EBITDA of $3.7 million. The company also received FDA 510(k) clearance for its next-generation airway clearance device and repurchased $1.1 million of stock.YahooTactile Systems Technology, Inc. Q4 2025 Earnings Call SummaryTactile Systems Technology reported strong Q4 2025 performance driven by sales force maturation, a favorable Medicare National Coverage Determination for lymphedema treatment, and 66% year-over-year growth in airway clearance revenue. The company completed its acquisition of LymphaTech, retired its term loan, and executed stock repurchases, positioning itself toward durable cash flow generation. Management provided 2026 revenue guidance of $357 million to $365 million, while flagging new CMS prior authorization requirements for pneumatic compression devices effective April 2026 as a potential short-term administrative headwind.BenzingaTactile Systems Technology Analysts Raise Their Forecasts After Better-Than-Expected Q4 Earnings - TactilTactile Systems Technology reported fourth-quarter earnings of 46 cents per share, beating the consensus estimate of 44 cents, with sales jumping 21% to $103.59 million driven by lymphedema and airway clearance products. The company also announced the acquisition of LymphaTech and raised its fiscal 2026 sales guidance to $357-365 million, above analyst expectations of $347.94 million. Analysts at BTIG and Piper Sandler responded by raising their price targets on the stock following the earnings announcement.BenzingaTactile Systems Stock Smashes 52-Week High After Strong Quarter - Tactile Systems Tech (NASDAQ:TCMD)Tactile Systems Technology announced better-than-expected fourth-quarter earnings, reporting 46 cents per share versus a 44-cent consensus estimate, with sales jumping 21% to $103.59 million. The company also completed the acquisition of LymphaTech for a $6.8 million upfront cash payment, with potential additional milestone-based consideration, to strengthen its lymphedema treatment capabilities. The earnings beat and strategic acquisition drove shares to a 52-week high, with the stock up 23.35% in premarket trading.Pulse 2.0Tactile Systems Acquires LymphaTech To Expand Lymphedema Solutions PortfolioTactile Systems Technology, doing business as Tactile Medical, has acquired LymphaTech Inc. for $6.8 million in upfront cash plus potential milestone payments. The acquisition adds LymphaTech's digital 3D full-body measurement and monitoring platform for lymphedema patients, expanding Tactile Medical's capabilities beyond device-based therapies into digital and connected care solutions. The transaction positions Tactile Medical to advance next-generation lymphatic therapies targeting approximately 20 million symptomatic patients in the United States.GlobeNewswireTactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions PortfolioTactile Systems Technology, Inc. (Tactile Medical) has acquired LymphaTech Inc. for an upfront cash payment of $6.8 million, plus potential additional consideration tied to future milestones. Founded in 2014, LymphaTech is a privately held medical technology company with a digital 3D full body measurement and monitoring platform designed for lymphedema assessment. The acquisition expands Tactile Medical's lymphedema portfolio with new solutions for disease identification and progression tracking, while strengthening the company's market leadership position in conditions associated with lymphatic dysfunction.